Alarming proportion of medical students in the UK intend to leave the NHS, survey reveals

Around 1 in 3 UK medical students plans to leave the NHS within 2 years of graduating-; either to practise abroad or to abandon medicine altogether-; suggest the results of the largest survey of its kind, published in the open access journal BMJ Open.

Roche’s gene therapy biotech Spark is laying off employees, ending some early-stage programs

Roche’s Spark Therapeutics is letting staffers go and has “discontinued” several early-stage programs, a spokesperson confirmed to Endpoints News. “In May, Spark informed employees in

July 12, 2024

Nuvectis launches Phase 1a dose escalation clinical trial of new cancer drug

Clinical trials have begun for a drug candidate for hard-to-treat cancers, discovered at the University of Edinburgh and licensed by US biopharmaceutical company Nuvectis Pharma,

September 15, 2023

Asceneuron secures $100m for neurodegenerative treatments

Asceneuron’s lead compound, ASN51, is intended for Alzheimer’s disease treatment. Credit: fizkes/Shutterstock. Clinical-stage biotech company Asceneuron has announced an oversubscribed Series C financing round, securing

July 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.